Topics

Shandong's Blue Sail Acquires New Valve Technology of Switzerland for $160 Million

02:07 EDT 26 Sep 2019 | ChinaBio Today

Blue Sail Medical of Shandong and Biosensors, a subsidiary of Blue Sail, will pay $160 million to acquire New Valve Technology, a Swiss medical device company. NVT specializes in safe, cost-effective, minimally invasive heart valve replacements. Its Allegra transcatheter aortic valve replacement device was approved in the EU in 2017. Blue Sail is known primarily for its disposable medical/surgical PVC gloves, while its Biosensors subsidiary, located in Singapore, makes stents, a complementary market to NVT's products. More details....

Stock Symbol: (SHZ: 2382)

Share this with colleagues:

Original Article: Shandong's Blue Sail Acquires New Valve Technology of Switzerland for $160 Million

NEXT ARTICLE

More From BioPortfolio on "Shandong's Blue Sail Acquires New Valve Technology of Switzerland for $160 Million"

Quick Search

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...